In this study, we evaluated the effects of α-
mangostin on cell growth inhibition and induction of apoptosis in MCF-7 ERα-positive human
breast cancer cells. Our results showed that α-
mangostin inhibited MCF-7 cell proliferation whereas ERα-negative MDA-MB-231 cells were less sensitive to the agent. Additionally, α-
mangostin effectively induced apoptosis as evidenced by the appearance of apoptotic nuclei observed with
Hoechst 33258 staining and evaluation of sub-G1
DNA contents by flow cytometry. α-
Mangostin also activated caspases-8, -9, and -7; increased the
protein levels of Bax, p53, and cytosolic
cytochrome c; and induced PARP cleavage while reducing Bid and Bcl-2
protein expression. In addition,
apoptosis-inducing factor (AIF) was transported from mitochondria to the cytosol after α-
mangostin treatment. α-
mangostin also induced apoptosis in 17-β-estradiol (E2)-stimulated MCF-7 cells in parallel with the non-stimulated cells. Moreover, treatment with 10μM α-
mangostin for 48h specifically decreased the expression of ERα and pS2, an
estrogen-responsive gene, in MCF-7 cells. Furthermore, knockdown of ERα expression in MCF-7 cells with
siRNA attenuated α-
mangostin-induced cell growth inhibition and
caspase-7 activation. These results suggest that ERα is required for α-
mangostin-induced growth inhibition and apoptosis in human
breast cancer cells. Therefore, α-
mangostin may be used to prevent and treat of ER-positive
breast cancer.